Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 2, 2011, Pages 416-422

  Fischer, Sarah Maud ^a,b   Brandl, Martin ^a   Fricker, Gert ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN; NADOLOL; NONIONIC SURFACTANT; POLOXAMER;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; ELECTRIC RESISTANCE; EPITHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICELLE; MICELLIZATION; MONOLAYER CULTURE; PASSIVE TRANSPORT; SOLUBILIZATION; ULTRAFILTRATION;

EID: 80054996010     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.04.010     Document Type: Article

References (38)

1. A.T. Serajuddin, Salt formation to improve drug solubility, Adv. Drug Deliv. Rev. 59 (2007) 603-616. (Pubitemid 47285406)
2. V.J. Stella, K.W. Nti-Addae, Prodrug strategies to overcome poor water solubility, Adv. Drug Deliv. Rev. 59 (2007) 677-694. (Pubitemid 47285410)
3. D.T. Friesen, R. Shanker, M. Crew, D.T. Smithey, W.J. Curatolo, J.A. Nightingale, Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview, Mol. Pharm. 5 (2008) 1003-1019.
4. M.E. Davis, M.E. Brewster, Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug Discov. 3 (2004) 1023-1035. (Pubitemid 39642365)
5. E.M. Merisko-Liversidge, G.G. Liversidge, Drug nanoparticles: formulating poorly water-soluble compounds, Toxicol. Pathol. 36 (2008) 43-48.
6. C.W. Pouton, Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems, Eur. J. Pharm. Sci. 11 (2) (2000) S93-98.
7. A.T. Serajuddin, Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs, J. Pharm. Sci. 88 (1999) 1058-1066.
8. V.P. Torchilin, Micellar nanocarriers: pharmaceutical perspectives, Pharm. Res. 24 (2007) 1-16. (Pubitemid 44902565)
9. T. Vasconcelos, B. Sarmento, P. Costa, Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs, Drug Discov. Today 12 (2007) 1068-1075. (Pubitemid 350186132)
10. N.S. Barakat, Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation, J. Pharm. Pharmacol. 62 (2010) 173- 180.
11. H. Tonsberg, R. Holm, J. Bisgaard, J. Jacobsen, A. Mullertz, Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats, J. Pharm. Pharmacol. 62 (2010) 63-70.
12. F.G. Poelma, R. Breas, J.J. Tukker, D.J. Crommelin, Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat, J. Pharm. Pharmacol. 43 (1991) 317-324.
13. F.M. Ingels, P.F. Augustijns, Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2, J. Pharm. Sci. 92 (2003) 1545-1558. (Pubitemid 36929675)
14. J. Kanzer, I. Tho, G.E. Flaten, M. Magerlein, P. Holig, G. Fricker, M. Brandl, Invitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier, J. Pharm. Pharmacol. 62 (2010) 1591-1598.
15. D.S. Pisal, V.K. Yellepeddi, A. Kumar, R.S. Kaushik, M.B. Hildreth, X. Guan, S. Palakurthi, Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers, Int. J. Pharm. 350 (2008) 113-121.
16. K. Bogman, F. Erne-Brand, J. Alsenz, J. Drewe, The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins, J. Pharm. Sci. 92 (2003) 1250-1261. (Pubitemid 36676470)
17. P. Saha, J.H. Kou, Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers, Eur. J. Pharm. Biopharm. 50 (2000) 403-411.
18. K.H. Song, S.J. Chung, C.K. Shim, Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts, J. Controlled Release 106 (2005) 298-308.
19. B.D. Rege, J.P. Kao, J.E. Polli, Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers, Eur. J. Pharm. Sci. 16 (2002) 237-246.
20. C. Hilgendorf, H. Spahn-Langguth, C.G. Regardh, E. Lipka, G.L. Amidon, P. Langguth, Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport, J. Pharm. Sci. 89 (2000) 63-75. (Pubitemid 30080155)
21. J. Smalley, P. Kadiyala, B. Xin, P. Balimane, T. Olah, Development of an on-line extraction turbulent flow chromatography tandem mass spectrometry method for cassette analysis of Caco-2 cell based bi-directional assay samples, J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 830 (2006) 270-277. (Pubitemid 43075462)
22. C.F. Mu, P. Balakrishnan, F.D. Cui, Y.M. Yin, Y.B. Lee, H.G. Choi, C.S. Yong, S.J. Chung, C.K. Shim, D.D. Kim, The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel, Biomaterials 31 (2010) 2371-2379.
23. X. Qin, F. Yuan, D. Zhou, Y. Huang, Oral characteristics of bergenin and the effect of absorption enhancers in situ, in vitro and in vivo, Arzneimittelforschung 60 (2010) 198-204.
24. M. Newa, K.H. Bhandari, D.X. Li, T.H. Kwon, J.A. Kim, B.K. Yoo, J.S. Woo, W.S. Lyoo, C.S. Yong, H.G. Choi, Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with Poloxamer 188, Int. J. Pharm. 343 (2007) 228-237. (Pubitemid 47321028)
25. C.S. Yong, M.K. Lee, Y.J. Park, K.H. Kong, J.J. Xuan, J.H. Kim, J.A. Kim, W.S. Lyoo, S.S. Han, J.D. Rhee, J.O. Kim, C.H. Yang, C.K. Kim, H.G. Choi, Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using Poloxamer 188 and menthol, Drug Dev. Ind. Pharm. 31 (2005) 615-622. (Pubitemid 41356203)
26. F. Seeballuck, M.B. Ashford, C.M. O'Driscoll, The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells, Pharm. Res. 20 (2003) 1085- 1092. (Pubitemid 36774280)
27. J. Parmentier, F.J. Hartmann, G. Fricker, In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules, Eur. J. Pharm. Biopharm. 76 (2010) 394-403.
28. M. Greulich, Einfluss von Tensiden auf die Resorption von Substraten der ABCTransportproteine, in: Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, 2003, p. 91.
29. E.V. Batrakova, H.Y. Han, V. Alakhov, D.W. Miller, A.V. Kabanov, Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers, Pharm. Res. 15 (1998) 850-855. (Pubitemid 28307825)
30. B.J. Aungst, Intestinal permeation enhancers, J. Pharm. Sci. 89 (2000) 429-442.
31. D. Dimitrijevic, A.J. Shaw, A.T. Florence, Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells, J. Pharm. Pharmacol. 52 (2000) 157-162. (Pubitemid 30125297)
32. Y. Takahashi, H. Kondo, T. Yasuda, T. Watanabe, S. Kobayashi, S. Yokohama, Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs, Int. J. Pharm. 246 (2002) 85-94. (Pubitemid 35247981)
33. E.V. Batrakova, A.V. Kabanov, Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers, J. Controlled Release 130 (2008) 98-106.
34. E.V. Batrakova, H.Y. Han, D.W. Miller, A.V. Kabanov, Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells, Pharm. Res. 15 (1998) 1525-1532. (Pubitemid 28465737)
35. S. Neuhoff, P. Artursson, I. Zamora, A.L. Ungell, Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells, Pharm. Res. 23 (2006) 350-359. (Pubitemid 43239592)
36. K. Katneni, S.A. Charman, C.J. Porter, Permeability assessment of poorly watersoluble compounds under solubilizing conditions: the reciprocal permeability approach, J. Pharm. Sci. 95 (2006) 2170-2185. (Pubitemid 44568528)
37. C. Hansch, P.G. Sammes, J.B. Taylor, Comprehensive medicinal chemistry: the rational design, 1st ed., Mechanistic Study & Therapeutic Application of Chemical Compounds, Pergamon Press, Oxford, New York, 1990.
38. S. Thomas, F. Brightman, H. Gill, S. Lee, B. Pufong, Simulation modelling of human intestinal absorption using Caco-2 permeability and kinetic solubility data for early drug discovery, J. Pharm. Sci. 97 (2008) 4557- 4574.